AbbVie, Inc. is a company in the U.S. stock market and it is a holding in 216 U.S.-traded ETFs. ABBV has around 102.0M shares in the U.S. ETF market. The largest ETF holder of ABBV is the SPDR S&P 500 ETF Trust (SPY), with approximately 16.55M shares. Investors may also find of interest that the ETF with the largest allocation to ABBV stock is VanEck Vectors Pharmaceutical ETF (PPH), with a portfolio weight of 5.61%. On average, U.S. ETFs allocate 1.13% of ABBV to their portfolios.
Additionally, ABBV is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ABBV as a holding is the ProShares UltraPro S&P500 (UPRO), with a return of 56.40%.